Substance Use Screening Among Drug User

October 31, 2016 updated by: DU, Jiang, Shanghai Mental Health Center

Screening and Brief Interventions for Substance Use in Primary Medical Institution

The purpose of this research is to improve the ability of primary medical staffs in screening and intervention for alcohol, benzodiazepines, and other illicit drug use.

Study Overview

Status

Unknown

Conditions

Detailed Description

In order to reduce the social and personal harm caused by drugs, it is urgent to strengthen the ability of the primary health institutions in screening and intervention the addictive substances use. Firstly, the investigators will invite 10 primary medical staffs and 10 experts in addition to revise the manual of Alcohol, Smoking, and Substance Use Involvement Screening Test (ASSIST) and Brief Intervention (BI). Then, the investigators will recruit 100 medical staffs to participate the training of ASSIST and BI. Secondly, the researcher will investigate the effects of BI technology in reducing the use of addictive substances, improve the addiction related knowledge of patients through randomized controlled study. Finally, the investigators will collect the research information, revise the manual, and promote the training.

Study Type

Interventional

Enrollment (Anticipated)

218

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. aged 18-60 years;
  2. the patient to the community medical institutions;
  3. ASSIST score is in 12-27, in a moderate risk;
  4. voluntary to participate;
  5. to agree to complete baseline interviews and follow-up studies.

Exclusion Criteria:

  1. unable to complete the questionnaire;
  2. serious physical illness, action inconvenience.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention Group
The medical staffs who received the training will use the manual of brief intervention to deliver it and other materials about the harm of substance use.
The medical staffs who received the training will use the manual of brief intervention to deliver BI and other materials about the harm of substance use.
Active Comparator: Control Group
The participants only receive the materials about the harm of substance use.
The participants only receive the materials about the harm of substance use.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Risk Behaviors measured by ASSIST questionnaire
Time Frame: 1 month
Risk Behaviors will be measured by ASSIST questionnaire.
1 month
Knowledge related to Substance Use measured by Knowledge related to Addiction questionnaire
Time Frame: 1 month
Knowledge related to substance use will be measured by Knowledge related to Addiction questionnaire.
1 month
Motivation measured by Pre-treatment Readiness Scale
Time Frame: 1 month
Motivation will be measured by Pre-treatment Readiness Scale (PRS).
1 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Depression measured by Self-Rating Depression Scale
Time Frame: 1 month
the change of depression will be measured by Self-Rating Depression Scale (SDS).
1 month
Anxiety measured by Self-Rating Anxiety Scale
Time Frame: 1 month
the change of anxiety will be measured by Self-Rating Anxiety Scale (SAS).
1 month
Self-esteem measured by Self-esteem questionnaire
Time Frame: 1 month
the change of self-esteem will be measured by Self-esteem questionnaire.
1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jiang Du, M.D, Shanghai Mental Health Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2017

Primary Completion (Anticipated)

December 1, 2018

Study Registration Dates

First Submitted

October 23, 2016

First Submitted That Met QC Criteria

October 31, 2016

First Posted (Estimate)

November 1, 2016

Study Record Updates

Last Update Posted (Estimate)

November 1, 2016

Last Update Submitted That Met QC Criteria

October 31, 2016

Last Verified

October 1, 2016

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Substance Use

Clinical Trials on Intervention Group

3
Subscribe